Karen Rodriguez-Lua

Prucalopride repurposing: 5-HT4 receptor agonists in anxiety and depression.

Major depressive disorder remains a leading cause of disability worldwide, and current antidepressant treatments are limited by a delayed onset of action, modest remission rates, and residual symptoms. Emerging evidence suggests that selective targeting of specific serotonergic receptors may offer faster and more preci...